Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BFLY NASDAQ:EYE NYSE:INSP NASDAQ:LQDA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$2.36+2.8%$1.76$1.32▼$4.98$592.85M2.594.23 million shs5.37 million shsEYENational Vision$27.15+0.9%$25.07$9.56▼$29.59$2.15B1.32.09 million shs1.33 million shsINSPInspire Medical Systems$78.92+0.1%$82.86$70.77▼$216.01$2.33B1.16748,140 shs563,292 shsLQDALiquidia Technologies$23.16+1.7%$25.00$9.71▼$29.94$1.99B0.151.94 million shs1.99 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network0.00%-8.38%+46.65%+27.86%+32.66%EYENational Vision+2.01%-3.24%+17.01%+6.16%+172.54%INSPInspire Medical Systems+1.54%+2.47%-1.88%-38.18%-62.57%LQDALiquidia Technologies-4.21%-5.20%-12.39%+60.47%+104.49%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$2.36+2.8%$1.76$1.32▼$4.98$592.85M2.594.23 million shs5.37 million shsEYENational Vision$27.15+0.9%$25.07$9.56▼$29.59$2.15B1.32.09 million shs1.33 million shsINSPInspire Medical Systems$78.92+0.1%$82.86$70.77▼$216.01$2.33B1.16748,140 shs563,292 shsLQDALiquidia Technologies$23.16+1.7%$25.00$9.71▼$29.94$1.99B0.151.94 million shs1.99 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network0.00%-8.38%+46.65%+27.86%+32.66%EYENational Vision+2.01%-3.24%+17.01%+6.16%+172.54%INSPInspire Medical Systems+1.54%+2.47%-1.88%-38.18%-62.57%LQDALiquidia Technologies-4.21%-5.20%-12.39%+60.47%+104.49%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFLYButterfly Network 2.40Hold$3.0027.39% UpsideEYENational Vision 2.45Hold$24.73-8.92% DownsideINSPInspire Medical Systems 2.40Hold$148.0087.52% UpsideLQDALiquidia Technologies 2.70Moderate Buy$32.3839.79% UpsideCurrent Analyst Ratings BreakdownLatest BFLY, INSP, EYE, and LQDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/15/2025INSPInspire Medical SystemsTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$125.00 ➝ $90.0010/10/2025INSPInspire Medical SystemsRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$150.0010/8/2025BFLYButterfly NetworkWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025EYENational VisionWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025INSPInspire Medical SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/8/2025LQDALiquidia TechnologiesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/7/2025INSPInspire Medical SystemsEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$150.00 ➝ $125.0010/6/2025LQDALiquidia TechnologiesHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$35.009/27/2025BFLYButterfly NetworkWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025EYENational VisionWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025INSPInspire Medical SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)(Data available from 10/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFLYButterfly Network$82.06M7.22N/AN/A$0.79 per share2.98EYENational Vision$1.82B1.18$1.68 per share16.12$10.37 per share2.62INSPInspire Medical Systems$802.80M2.91$1.74 per share45.47$23.01 per share3.43LQDALiquidia Technologies$14M142.42N/AN/A$0.91 per share25.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFLYButterfly Network-$72.49M-$0.28N/AN/AN/A-71.79%-30.53%-21.80%11/7/2025 (Estimated)EYENational Vision-$28.50M-$0.18N/A100.562.92-0.75%3.56%1.49%11/5/2025 (Estimated)INSPInspire Medical Systems$53.51M$1.7345.6224.512.426.17%10.38%8.93%11/3/2025 (Estimated)LQDALiquidia Technologies-$130.39M-$1.70N/AN/AN/A-732.17%-232.96%-60.81%11/12/2025 (Estimated)Latest BFLY, INSP, EYE, and LQDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/12/2025Q3 2025LQDALiquidia Technologies-$0.45N/AN/AN/A$18.86 millionN/A11/7/2025Q3 2025BFLYButterfly Network-$0.07N/AN/AN/AN/AN/A11/5/2025Q3 2025EYENational Vision$0.12N/AN/AN/A$472.98 millionN/A11/3/2025Q3 2025INSPInspire Medical Systems-$0.11N/AN/AN/A$220.39 millionN/A8/12/2025Q2 2025LQDALiquidia Technologies-$0.43-$0.49-$0.06-$0.49$3.90 million$8.84 million8/6/2025Q2 2025EYENational Vision$0.12$0.18+$0.06$0.11$469.21 million$486.42 million8/4/2025Q2 2025INSPInspire Medical Systems$0.22$0.45+$0.23-$0.12$214.50 million$217.09 million8/1/2025Q2 2025BFLYButterfly Network-$0.07-$0.06+$0.01-$0.06$23.91 million$23.38 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBFLYButterfly NetworkN/AN/AN/AN/AN/AEYENational VisionN/AN/AN/AN/AN/AINSPInspire Medical SystemsN/AN/AN/AN/AN/ALQDALiquidia TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFLYButterfly NetworkN/A5.684.14EYENational Vision0.300.520.31INSPInspire Medical SystemsN/A6.144.84LQDALiquidia Technologies9.842.492.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFLYButterfly Network37.85%EYENational VisionN/AINSPInspire Medical Systems94.91%LQDALiquidia Technologies64.54%Insider OwnershipCompanyInsider OwnershipBFLYButterfly Network25.18%EYENational Vision2.70%INSPInspire Medical Systems2.30%LQDALiquidia Technologies30.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFLYButterfly Network460251.74 million188.35 millionOptionableEYENational Vision13,41179.20 million77.06 millionOptionableINSPInspire Medical Systems1,24629.57 million28.89 millionOptionableLQDALiquidia Technologies5086.09 million60.18 millionOptionableBFLY, INSP, EYE, and LQDA HeadlinesRecent News About These CompaniesLiquidia Technologies, Inc. (NASDAQ:LQDA) Receives Average Rating of "Moderate Buy" from AnalystsOctober 13 at 2:39 AM | americanbankingnews.comLiquidia Technologies, Inc. (NASDAQ:LQDA) Given Average Rating of "Moderate Buy" by AnalystsOctober 13 at 2:37 AM | marketbeat.comLiquidia Technologies (NASDAQ:LQDA) Receives Sell (D-) Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comSmart Money Is Betting Big In LQDA OptionsOctober 8, 2025 | benzinga.comLiquidia Technologies (NASDAQ:LQDA) Stock Price Up 4.3% - Still a Buy?October 7, 2025 | marketbeat.comLiquidia Corporation to Host R&D Day in New York City on October 28, 2025October 7, 2025 | globenewswire.comLiquidia Technologies' (LQDA) "Buy" Rating Reiterated at HC WainwrightOctober 7, 2025 | americanbankingnews.comWhat 5 Analyst Ratings Have To Say About LiquidiaOctober 6, 2025 | benzinga.comHC Wainwright Reaffirms Buy Rating for Liquidia Technologies (NASDAQ:LQDA)October 6, 2025 | marketbeat.comBTIG biotech analyst holds an analyst/industry conference callOctober 4, 2025 | msn.comLiquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual MeetingSeptember 29, 2025 | finance.yahoo.comLiquidia Technologies (NASDAQ:LQDA) Stock Price Down 5.1% - Time to Sell?September 26, 2025 | marketbeat.comLiquidia Technologies (NASDAQ:LQDA) Shares Gap Up - What's Next?September 25, 2025 | marketbeat.comIs it a Wise Move to Buy Liquidia Corp. (LQDA) Shares?September 23, 2025 | insidermonkey.comRaman Singh Sells 45,524 Shares of Liquidia Technologies (NASDAQ:LQDA) StockSeptember 18, 2025 | marketbeat.comLiquidia Technologies (NASDAQ:LQDA) Director Raman Singh Sells 45,524 SharesSeptember 18, 2025 | insidertrades.comSapient Capital LLC Reduces Stake in Liquidia Technologies, Inc. $LQDASeptember 18, 2025 | marketbeat.comLiquidia Technologies, Inc. (NASDAQ:LQDA) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 18, 2025 | marketbeat.comLiquidia Corporation (LQDA): A Bull Case Theory September 16, 2025 | insidermonkey.comLiquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) SymposiumSeptember 11, 2025 | markets.businessinsider.comLiquidia Technologies (NASDAQ:LQDA) Director Sells $220,650.00 in StockSeptember 6, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCrowdStrike’s Investor Day Sparks Bullish MomentumBy Chris Markoch | September 26, 2025Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300By Sam Quirke | September 29, 2025Cybersecurity Market Set to Double: This ETF Offers ExposureBy Jordan Chussler | September 24, 2025Palantir Stock Eyes New Highs, Boosted by Boeing PartnershipBy Chris Markoch | October 1, 2025Palantir Expands UK Defense Role, Stock Eyes New HighsBy Chris Markoch | September 23, 2025BFLY, INSP, EYE, and LQDA Company DescriptionsButterfly Network NYSE:BFLY$2.36 +0.07 (+2.84%) Closing price 03:59 PM EasternExtended Trading$2.38 +0.02 (+1.06%) As of 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.National Vision NASDAQ:EYE$27.15 +0.25 (+0.93%) Closing price 04:00 PM EasternExtended Trading$26.25 -0.90 (-3.31%) As of 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Inspire Medical Systems NYSE:INSP$78.92 +0.08 (+0.11%) Closing price 03:59 PM EasternExtended Trading$78.86 -0.07 (-0.09%) As of 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.Liquidia Technologies NASDAQ:LQDA$23.16 +0.39 (+1.71%) Closing price 04:00 PM EasternExtended Trading$23.70 +0.54 (+2.35%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Walmart's AI Play: OpenAI Deal Forges a New Path to Profitability 3 Healthcare Companies Insiders Are Buying Tempus AI Hits $100—Are Shares Due for a Pullback? Vertiv Stock Surges on Strategic CFO Hire and AI Momentum NVIDIA Analysts Lift Targets: What It Means for the Stock Price Fastenal Stock Pulls Back in October—Is It Time to Buy FAST? 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise Why Congress Is Buying Intuitive Surgical Ahead of Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
